Endurant Capital Management LP Charles River Laboratories International, Inc. Transaction History

Endurant Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $1.23 Million - $1.56 Million	6,258 New	6,258 $1.36 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $675,262 - $1 Million	-3,308 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $3.9 Million - $5.53 Million	-15,278 Reduced 82.2%	3,308 $939,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $6.53 Million - $8.34 Million	18,586 New	18,586 $7 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $1.56 Million - $2.49 Million	-13,147 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $1.3 Million - $2.34 Million	13,147 New	13,147 $1.66 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $9.45 Million - $11.5 Million	-74,986 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $9.38 Million - $10.8 Million	74,986 New	74,986 $9.93 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.